Achieve Life Sciences Inc (ACHV)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -46.987 | -56.651 | -87.569 | -81.644 | -47.999 | -75.505 | -109.309 | -120.85 |
Return on Equity (%) | -71.372 | -78.845 | -107.149 | -96.863 | -53.238 | -101.494 | -233.044 | -869.876 |
Return on Invested Capital (%) | -79.477 | -25.329 | -108.702 | -97.002 | -52.731 | -82.26 | -159.119 | -805.425 |
Operating Margin (%) | -397.649 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | -397.649 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.632 | 0.361 | 1.854 | 2.221 | 5.626 | 2.683 | 0.327 | -0.174 |
Earnings Per Share | -0.67 | -0.886 | -1.888 | -2.439 | -2.41 | -3.507 | -2.366 | -1.409 |
Cash Per Share | 0.507 | 0.442 | 1.416 | 2.479 | 5.866 | 4.551 | 1.384 | 0.734 |
Working Capital Per Share | 0.615 | 0.326 | 1.825 | 2.152 | 5.569 | 4.236 | 0.32 | -0.181 |
Operating Profit Per Share | 0.169 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.67 | -1.141 | -1.888 | -2.439 | -2.41 | -3.507 | -2.366 | -1.409 |
EBITDA Per Share | -0.67 | -1.141 | -1.888 | -2.439 | -2.41 | -3.507 | -2.366 | -1.409 |
Free Cash Flow Per Share | -0.675 | -0.909 | -1.923 | -2.469 | -2.449 | -3.533 | -2.38 | -1.418 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 30,03M | 11,95M | 6,72M | 6,72M | 6,11M | 9,45M | 17,9M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 17,9M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 126,9M |
Ratio cours/bénéfice | -4,26 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 8,16 |
Ratio prix/valeur comptable | -87,64 |
Rendement de dividende | - |
Actions en circulation | 34,39M |
Volume moyen (1 semaine) | 160,77k |
Volume moyen (1 mois) | 155,84k |
Variation sur 52 semaines | -9,51% |
Plus haut sur 52 semaines | 5,59 |
Plus bas sur 52 semaines | 3,42 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales